This article is part of the supplement: Report of a Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas
Email this article to a friend
Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.
-
* Corresponding author: Charles D Mackenzie tropmed@juno.com
Filaria Journal 2003, 2(Suppl 1):S5 doi:10.1186/1475-2883-2-S1-S5